Limited access to targeted therapies and immunotherapies as well as the aggressive nature of metastatic or recurrent cervical cancer are a few of the barriers to care that affect patients internationally; especially those who seek treatment in low- and middle-income countries. According to a recent analysis of real-world data, those barriers and access to effective palliative chemotherapy treatments play a role both in patient access to cervical cancer care and survival outcomes. ...
Advertisement
Latest News
Patients with metastatic breast cancer experienced reduced fatigue interference with functioning with the addition of ACT.
Oncology nurses are integral to the success of ECP, as they provide ongoing education and psychosocial support to patients.
As we observe Veterans Day this month, it's critical to remember that military service is a key patient assessment point.
The study analyzed how decision making and quality of life contribute to treatment regret in patients with prostate cancer.
The integrative literature review evaluated clinician and patient experiences and outcomes for nurse-led flexible cystoscopy.
Hear expert insights on how GVHD research is evolving as investigators evaluate new prevention and treatment strategies.
The multi-site, retrospective study assessed patients with advanced urothelial carcinoma and neuropathy or diabetes mellitus.
Before axatilimab, targeting the CSF-1R pathway was not previously studied in cGVHD.
New research and therapeutic approaches are challenging long-held beliefs about this type of graft.
Lisa Hwa, APRN, CNP, DNP, MS, said the comprehensive fellowships will help prepare APPs working in complex specialties.
As a nonpharmacological intervention with high acceptability and enjoyment, virtual reality may be an effective strategy.
In addition to knowing what herbal products patients take, it’s equally as important to understand why they take them.
Advertisement
Advertisement
Our Contributors
Theresa Brown, RNTheresa Brown, RN, is the New York Times best-selling author of "Healing" and "The Shift."
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®, is the owner of beyond Oncology Education, LLC.
Milagros Elia, MA, APRN, ANP-BCMilagros R. Elia, MA, APRN, ANP-BC, has 25+ years of oncology experience and is a highly regarded activist.
Pamela K. Ginex, EdD, MPH, RN, OCNPamela K. Ginex, EdD, MPH, RN, OCN, is an Assistant Professor at the Stony Brook University School of Nursing.
Teresa Hagan Thomas, PhD, RNTeresa Hagan Thomas, PhD, RN, is an Assistant Professor at the University of Pittsburgh School of Nursing.
Amanda Brink, DNP, APRN, FNP-BC, AOCNPAmanda Brink, DNP, APRN, FNP-BC, AOCNP, is an oncology nurse practitioner at the MD Anderson Cancer Center.
Alicia Michaelsen, BSN, RN, BMTCN®Alicia Michaelsen, BSN, RN, BMTCN®, is a nurse with over a decade of experience.
Fatemeh Youssefi, PhD, RN, OCNFatemeh Youssefi, PhD, RN, OCN, is a nurse who has specialized in oncology for the past 20 years.
Expert Interviews
Cancer Nursing Today delivers critical news and expert insights to support oncology nurses throughout their education and careers.
Sign up to receive Cancer Nursing Today eNewsletters:
Conference Highlights
Lisa Hwa, APRN, CNP, DNP, MS, said the comprehensive fellowships will help prepare APPs working in complex specialties.
Learn how a team developed a predictive model for breast cancer using cfDNA low-pass whole genome sequencing.
The study analyzed quality-adjusted time without symptoms of disease progression or toxicity of treatment, known as Q-TWiST.
Patients who received the vaccine within 100 days of starting an immune checkpoint inhibitor showed improved survival.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.